Mayfield Group Holdings Limited (ASX:MYG)

Sage Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Operating Revenue	99.03	85.69	77.82	82.33	60.79	60.52
Revenue	99.03	85.69	77.82	82.33	60.79	60.52
Revenue Growth (YoY)	32.93%	10.12%	-5.48%	35.44%	0.44%	-8.53%
Cost of Revenue	52.42	42.95	36.08	45.44	29.34	27.03
Gross Profit	46.6	42.75	41.74	36.89	31.45	33.49
Selling, General & Admin	35.41	31.6	31.58	33.84	27.6	26.68
Other Operating Expenses	4.81	4.62	3.8	3.59	2.87	2.21
Operating Expenses	42.17	38.25	37.51	39.59	32.6	30.73
Operating Income	4.43	4.5	4.22	-2.7	-1.15	2.76
Interest Expense	-0.19	-0.18	-0.34	-0.24	-0.2	-0.26
Interest & Investment Income	0.51	0.32	0.02	0.01	0	0.01
Earnings From Equity Investments	-	-	-	0.22	0.43	0.08
Currency Exchange Gain (Loss)	0.02	0.02	0	0.04	0.14	0.24
Other Non Operating Income (Expenses)	-	-	-	-	3.09	1.33
EBT Excluding Unusual Items	4.77	4.65	3.9	-2.68	2.31	4.16
Gain (Loss) on Sale of Assets	0.02	0.11	-	0.07	0.08	0.01
Other Unusual Items	-	-	-	-	0.76	-
Pretax Income	4.79	4.76	3.9	-2.61	3.15	4.16
Income Tax Expense	0.48	-0.34	-1.89	-0.79	0.55	1.67
Earnings From Continuing Operations	4.31	5.1	5.8	-1.81	2.6	2.49
Minority Interest in Earnings	-	-	-	-	-0.02	-0.06
Net Income	4.31	5.1	5.8	-1.81	2.58	2.43
Net Income to Common	4.31	5.1	5.8	-1.81	2.58	2.43
Net Income Growth	-40.42%	-12.00%	-	-	6.39%	-28.36%
Shares Outstanding (Basic)	91	91	91	89	79	69
Shares Outstanding (Diluted)	93	92	91	89	80	72
Shares Change (YoY)	2.20%	1.26%	1.96%	11.67%	9.95%	645999.88%
EPS (Basic)	0.05	0.06	0.06	-0.02	0.03	0.04
EPS (Diluted)	0.05	0.06	0.06	-0.02	0.03	0.03
EPS Growth	-41.60%	-13.12%	-	-	-3.29%	-99.99%
Free Cash Flow	6.05	15.27	7.72	0.77	-8.58	-1.38
Free Cash Flow Per Share	0.07	0.17	0.09	0.01	-0.11	-0.02
Dividend Per Share	0.030	0.030	0.017	-	-	-
Dividend Growth	50.00%	75.44%	-	-	-	-
Gross Margin	47.06%	49.88%	53.63%	44.81%	51.74%	55.33%
Operating Margin	4.47%	5.25%	5.43%	-3.28%	-1.89%	4.56%
Profit Margin	4.35%	5.95%	7.45%	-2.20%	4.25%	4.01%
Free Cash Flow Margin	6.11%	17.82%	9.92%	0.94%	-14.11%	-2.28%
EBITDA	5.33	5.47	5.33	-1.48	0.02	3.71
EBITDA Margin	5.38%	6.38%	6.85%	-1.80%	0.03%	6.12%
D&A For EBITDA	0.9	0.97	1.11	1.22	1.17	0.95
EBIT	4.43	4.5	4.22	-2.7	-1.15	2.76
EBIT Margin	4.47%	5.25%	5.43%	-3.28%	-1.89%	4.56%
Effective Tax Rate	10.06%	-	-	-	17.35%	40.14%
Advertising Expenses	-	-	-	-	0.15	0.17

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.